Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
TG2-H5253 | Human | Human TGF-beta RII / TGFBR2 Protein, Llama IgG2b Fc Tag (MALS verified) |
|
|
|
TG2-M82H5 | Mouse | Biotinylated Mouse TGF-beta RII / TGFBR2 Protein, His,Avitag™ |
|
|
|
TG2-H52H5 | Human | Human TGF-beta RII / TGFBR2 Protein, His Tag |
|
|
|
TG2-H82E4 | Human | Biotinylated Human TGF-beta RII / TGFBR2 Protein, His,Avitag™ |
|
|
|
TG2-H82F6 | Human | Biotinylated Human TGF-beta RII / TGFBR2 Protein, Fc,Avitag™ (MALS verified) |
|
|
|
TG2-H5252 | Human | Human TGF-beta RII / TGFBR2 Protein, Fc Tag (MALS verified) |
|
|
Immobilized Human Latent TGFB1, His Tag (Cat. No. TG1-H524x) at 1 μg/mL (100 μL/well) can bind Biotinylated Mouse TGF-beta RII, His,Avitag (Cat. No. TG2-M82H5) with a linear range of 1-31 ng/mL (QC tested).
The purity of Human TGF-beta RII Protein, Llama IgG2b Fc Tag (Cat. No. TG2-H5253) is more than 85% and the molecular weight of this protein is around 95-115 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
HCW-9218 | HCW-9218 | Phase 2 Clinical | HCW Biologics Inc | Solid tumours; Pancreatic Neoplasms; Pulmonary Fibrosis | Details |
INCA33890 | INCA33890; INCA-33890 | Phase 1 Clinical | Incyte Corp | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
RG-6315 | RG-6315 | Phase 1 Clinical | Genentech Inc | Scleroderma, Systemic | Details |
TASO-001 | TASO-001; ATB-301 | Phase 1 Clinical | Autotelicbio Co Ltd | Solid tumours | Details |
HCW-9218 | HCW-9218 | Phase 2 Clinical | HCW Biologics Inc | Solid tumours; Pancreatic Neoplasms; Pulmonary Fibrosis | Details |
INCA33890 | INCA33890; INCA-33890 | Phase 1 Clinical | Incyte Corp | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
RG-6315 | RG-6315 | Phase 1 Clinical | Genentech Inc | Scleroderma, Systemic | Details |
TASO-001 | TASO-001; ATB-301 | Phase 1 Clinical | Autotelicbio Co Ltd | Solid tumours | Details |
This web search service is supported by Google Inc.